H. J. M. van Kan

Association between CYP1A2 activity and riluzole clearance in patients with amyotrophic lateral sclerosis

H. J. M. van Kan, Geert Jan Groeneveld, Sandra Kalmijn et al. · British Journal of Clinical Pharmacology · 2005 · 42 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Clinically relevant potential drug-drug interactions in intensive care patients: A large retrospective observational multicenter study

Tinka Bakker, Ameen Abu‐Hanna, Dave A. Dongelmans et al. · Journal of Critical Care · 2020 · 38 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Improving medication safety in the Intensive Care by identifying relevant drug-drug interactions - Results of a multicenter Delphi study

Tinka Bakker, Joanna E. Klopotowska, Nicolette F. de Keizer et al. · Journal of Critical Care · 2020 · 30 citations · Full text

Computing, Pharmacology, Clinical Decision Support +14

A validated HPLC assay to monitor riluzole plasma or serum concentrations in patients with amyotrophic lateral sclerosis

H. J. M. van Kan, M. Spieksma, Geert Jan Groeneveld et al. · Biomedical Chromatography · 2004 · 25 citations

Medicine, Neurology, Pharmacology +15

Acute kidney injury associated with nephrotoxic drugs in critically ill patients: a multicenter cohort study using electronic health record data

Izak Yasrebi‐de Kom, Dave A. Dongelmans, Ameen Abu–Hanna et al. · Clinical Kidney Journal · 2023 · 23 citations · Full text

Medicine, Nephrology, Pharmacology +15